• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 3.0MM X 24MM NO TIP- PMA; STENT, INTRACRANIAL NEUROVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 3.0MM X 24MM NO TIP- PMA; STENT, INTRACRANIAL NEUROVASCULAR Back to Search Results
Model Number M003UZAS30240
Device Problems Entrapment of Device (1212); Migration (4003)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 04/03/2023
Event Type  Injury  
Manufacturer Narrative
H3 other text : the device is not available to the manufacturer.
 
Event Description
It was reported that during the procedure, after successfully deploying the subject stent, the stent delivery wire could not be removed.The physician applied force in an attempt to remove the delivery wire which resulted in the proximal end of the subject stent dislodging and migrating to the a1/terminus.A clot began to form on the subject stent and integrilin was administered to the patient.The physician moved the proximal end of the subject stent back to the desired location using a guidewire.There was a 15 minute surgical delay and the patient is stable.
 
Manufacturer Narrative
H4 manufacturing date ¿ added d4 expiration date - added b2 outcomes attributed to ae- updated due to the automated manufacturing execution system (mes) there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Additional information provided by the customer was during the procedure, after successfully deploying the stent from the left m2 to m1, he could not remove the stent delivery wire (sdw).In an effort to remove the delivery wire, he pulled the wire harder.As a result, the proximal end of the stent dislodged and ended up in the a1/terminus.Clot began to form on the stent and integrilin was administered.He was able to move the proximal end of the stent back into place by using a guidewire with a j curve on it.Patient is ok.Minimal procedural delay was experienced.It was also reported that all products were prepped per their respective dfus, no anomalies were noted as the products were removed from their packages and continuous flush was set up and maintained during the procedure.While there are a number of potential causes for the reported issue, because review and analysis of available information failed to identify a definitive cause and the device was not returned, an assignable cause of undeterminable will be assigned to the reported sdw stuck in sent and stent dislodged/migrated.The risk of the reported patient vessel thrombosis is documented in the dfu, as potential adverse events which can occur as a result of these type of procedures, there was no indication of device malfunction or failure, therefore an assignable cause of anticipated procedural complication, will be assigned to the reported patient vessel thrombosis.
 
Event Description
It was reported that during the procedure, after successfully deploying the subject stent, the stent delivery wire could not be removed.The physician applied force in an attempt to remove the delivery wire which resulted in the proximal end of the subject stent dislodging and migrating to the a1/terminus.A clot began to form on the subject stent and integrilin was administered to the patient.The physician moved the proximal end of the subject stent back to the desired location using a guidewire.There was a 15 minute surgical delay and the patient is stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROFORM ATLAS 3.0MM X 24MM NO TIP- PMA
Type of Device
STENT, INTRACRANIAL NEUROVASCULAR
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key16815266
MDR Text Key314007950
Report Number3008881809-2023-00208
Device Sequence Number1
Product Code NJE
UDI-Device Identifier07613327382204
UDI-Public07613327382204
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM003UZAS30240
Device Catalogue NumberM003UZAS30240
Device Lot Number23972243
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SYNCHRO GUIDEWIRE (STRYKER).
Patient Outcome(s) Required Intervention; Other;
-
-